PIOGLITAZONE HCL 30 MG TABLET

pioglitazone hydrochloride
$0.0923per EA

Strength

30 mg/1

NDC

82009010405

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

PIOGLITAZONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA200268

On Market Since

8/1/2023

Pharmacological Classes

Peroxisome Proliferator Receptor alpha Agonist
Peroxisome Proliferator Receptor gamma Agonist
Peroxisome Proliferator-activated Receptor alpha Agonists
Peroxisome Proliferator-activated Receptor gamma Agonists
Thiazolidinedione
Thiazolidinediones

Price History

1W

0.0%

1M

-1.3%

3M

-2.7%

6M

-6.0%

1Y

-10.7%

3Y

N/A

5Y

N/A

All

-12.8%